Entity > Corporation > CA > Vancouver British Columbia > Repare Therapeutics
About Repare Therapeutics
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Repare Therapeutics
| Company Attribute | Value |
| Name | Repare Therapeutics |
| Url | reparerx |
Repare Therapeutics
Vancouver, CA
3 May 2024
Repare Therapeutics
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://www.reparerx.com/
Repare Therapeutics is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to developing novel medicines.
Rich Sitelinks
https://finance.yahoo.com › quote › RPTX
Repare Therapeutics Inc., a clinical-stage precision oncology company, engages in the discovery and development of therapeutics by using its synthetic ...
People Also Ask
https://ca.linkedin.com/company/repare-therapeutics
Our company was founded in 2016 by field-leading academics to systematically employ synthetic lethality insights and platforms and develop new ...
https://www.fiercebiotech.com › biotech › roche-dumps...
Feb 13, 2024 — Roche has made a fast U-turn on Repare Therapeutics' synthetic lethal drug candidate. Days after dosing a phase 2 patient and triggering a ...
https://twitter.com/RepareRx?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Twitter Boxes
https://www.admarebio.com › ecosystems-details › repa...
Repare Therapeutics is developing new precision oncology drugs that target specific vulnerabilities of tumor cells. Its approach integrates insights from ...
https://www.annualreports.com › Company › repare-the...
The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic ...
Related Searches
Repare therapeutics news
repare therapeutics location
repare therapeutics address
Knowledge Panel
Repare Therapeutics Inc (Biotech company)
Repare Therapeutics is developing new precision oncology drugs that target specific vulnerabilities of tumor cells. Its approach integrates insights from several fields of cell biology including DNA repair and synthetic lethality.
-
Stock price : RPTX (NASDAQ) US$3.35 +0.05 (+1.52%)May 2, 4:00 p.m. EDT - Disclaimer
-
Headquarters : Canada
-
Date founded : 2016
| Entity Home | Kalicube Pro Entity Page |